about
Rational Design of a Parthenolide-based Drug Regimen That Selectively Eradicates Acute Myelogenous Leukemia Stem CellsClathrin assembly protein CALM plays a critical role in KIT signaling by regulating its cellular transport from early to late endosomes in hematopoietic cells.Discovery of Power-Law Growth in the Self-Renewal of Heterogeneous Glioma Stem Cell PopulationsPreferential eradication of acute myelogenous leukemia stem cells by fenretinide.NK cells from an AML patient have recovered in remission and reached comparable cytolytic activity to that of a healthy monozygotic twin mediated by the single-chain triplebody SPM-2.Properties and feasibility of using cancer stem cells in clinical cancer treatment.Preclinical targeting of human acute myeloid leukemia and myeloablation using chimeric antigen receptor-modified T cells.How to improve the immunogenicity of chemotherapy and radiotherapy.Aldehyde dehydrogenases in acute myeloid leukemia.CD123 target validation and preclinical evaluation of ADCC activity of anti-CD123 antibody CSL362 in combination with NKs from AML patients in remission.Synthesis and antileukemic activities of C1-C10-modified parthenolide analogues.GPR56 contributes to the development of acute myeloid leukemia in mice.Chimeric antigen receptors for adoptive T cell therapy in acute myeloid leukemiaEvolution of acute myelogenous leukemia stem cell properties after treatment and progression.
P2860
Q28391575-5005BE9F-B70D-41EE-9087-49483A156D85Q34287371-FFCBC3D4-1D06-46DA-BB97-E1534EBE9C1DQ35748846-8D30BE1D-532E-4A50-8BB6-64D16F58C72AQ36747742-5AFDFEB8-54A4-4734-A554-EB0E83DAC645Q37348420-32F168C2-5581-4BA0-8325-9C2C4F6C6104Q37596687-4F1D12CA-29C2-44E4-A364-9D75B9BAAB84Q37697847-0029418D-D6F2-4C46-9E66-780064500432Q37836489-4BE32A45-A882-4156-9EBE-9741F685ADC2Q38196948-18D1216A-580A-45CF-88A8-E4452CCAFB65Q38748924-5DD182A0-6554-4586-9A7B-65976C922002Q38862410-F867705F-5672-41F7-A218-8DCEEECC345FQ40808168-576BD841-4B8A-4A71-BD8B-D75888BBD44CQ41558781-5743BAF3-9771-4890-9E20-E32C769D897BQ41663784-05120751-FD81-4911-B4C7-8249D5FAFD08
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on May 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Targeting myeloid leukemia stem cells.
@en
Targeting myeloid leukemia stem cells.
@nl
type
label
Targeting myeloid leukemia stem cells.
@en
Targeting myeloid leukemia stem cells.
@nl
prefLabel
Targeting myeloid leukemia stem cells.
@en
Targeting myeloid leukemia stem cells.
@nl
P2860
P1476
Targeting myeloid leukemia stem cells.
@en
P2093
Craig T Jordan
P2860
P304
P356
10.1126/SCITRANSLMED.3000914
P407
P577
2010-05-01T00:00:00Z